Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Sep 1;102(5):1051–1061. doi: 10.1172/JCI3687

VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

J C van der Loo 1, X Xiao 1, D McMillin 1, K Hashino 1, I Kato 1, D A Williams 1
PMCID: PMC508972  PMID: 9727075

Abstract

Fibronectin (FN), an extracellular matrix protein, is involved in the adhesion and migration of hematopoietic cells and has been shown to enhance retroviral gene transfer into primitive hematopoietic cells by co-localization of target cells and retrovirus when used as a substrate in vitro. We have previously found that mouse hematopoietic stem cells could be transduced on a FN fragment that included the recognition sequence Arg-Gly-Asp (RGD), suggesting that stem cells may express the integrin very late antigen (VLA)-5. To address this, we investigated the binding of mouse and human hematopoietic cells to recombinant peptides that contained one or a combination of the three principle cell-binding domains of FN. These domains included the VLA-5- binding sequence RGD, the VLA-4-binding site CS1, and the high affinity heparin-binding domain. Here we show that mouse long-term in vivo repopulating stem cells, as well as primitive human NOD/SCID mouse repopulating cells, can bind extracellular matrix protein FN by using integrin VLA-5 in vitro. This binding is specific and can be inhibited by antibodies to VLA-5. In addition, preincubation of BM cells with peptide CH-296, which contains all three primary FN-binding domains, decreased the engraftment of cells in the bone marrow in vivo, while intravenous injection of the same peptide induced an increase of progenitor cells in the spleen. In summary, our data demonstrate that VLA-5 is expressed on primitive mouse and human hematopoietic cells and suggest that there may be significant cooperation between integrin receptors and proteoglycan molecules in the engraftment of bone marrow cells and hematopoietic cell adhesion in vivo.

Full Text

The Full Text of this article is available as a PDF (289.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aota S., Nomizu M., Yamada K. M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem. 1994 Oct 7;269(40):24756–24761. [PubMed] [Google Scholar]
  2. Beauvais A., Erickson C. A., Goins T., Craig S. E., Humphries M. J., Thiery J. P., Dufour S. Changes in the fibronectin-specific integrin expression pattern modify the migratory behavior of sarcoma S180 cells in vitro and in the embryonic environment. J Cell Biol. 1995 Feb;128(4):699–713. doi: 10.1083/jcb.128.4.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bradley T. R., Hodgson G. S. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood. 1979 Dec;54(6):1446–1450. [PubMed] [Google Scholar]
  4. Craddock C. F., Nakamoto B., Elices M., Papayannopoulou T. h. The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking. Br J Haematol. 1997 Apr;97(1):15–21. doi: 10.1046/j.1365-2141.1997.d01-2120.x. [DOI] [PubMed] [Google Scholar]
  5. Crisa L., Cirulli V., Ellisman M. H., Ishii J. K., Elices M. J., Salomon D. R. Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4, and VLA5. J Exp Med. 1996 Jul 1;184(1):215–228. doi: 10.1084/jem.184.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Danen E. H., Aota S., van Kraats A. A., Yamada K. M., Ruiter D. J., van Muijen G. N. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. J Biol Chem. 1995 Sep 15;270(37):21612–21618. doi: 10.1074/jbc.270.37.21612. [DOI] [PubMed] [Google Scholar]
  7. Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1977 Jun;91(3):335–344. doi: 10.1002/jcp.1040910303. [DOI] [PubMed] [Google Scholar]
  8. Dufour S., Duband J. L., Humphries M. J., Obara M., Yamada K. M., Thiery J. P. Attachment, spreading and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules. EMBO J. 1988 Sep;7(9):2661–2671. doi: 10.1002/j.1460-2075.1988.tb03119.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gong J., Ko T. C., Brattain M. G. Disruption of fibronectin binding to the alpha 5 beta 1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase. J Biol Chem. 1998 Jan 16;273(3):1662–1669. doi: 10.1074/jbc.273.3.1662. [DOI] [PubMed] [Google Scholar]
  10. Hanenberg H., Xiao X. L., Dilloo D., Hashino K., Kato I., Williams D. A. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med. 1996 Aug;2(8):876–882. doi: 10.1038/nm0896-876. [DOI] [PubMed] [Google Scholar]
  11. Hashino K., Uemori Y., Kimizuka F., Kato I., Titani K. A 31-kDa recombinant fibronectin cell-binding domain fragment: its binding to receptor, cell adhesive activity, and fusion proteins. J Biochem. 1996 Apr;119(4):604–609. doi: 10.1093/oxfordjournals.jbchem.a021285. [DOI] [PubMed] [Google Scholar]
  12. Hirsch E., Iglesias A., Potocnik A. J., Hartmann U., Fässler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins. Nature. 1996 Mar 14;380(6570):171–175. doi: 10.1038/380171a0. [DOI] [PubMed] [Google Scholar]
  13. Hodgson G. S., Bradley T. R., Radley J. M. The organization of hemopoietic tissue as inferred from the effects of 5-fluorouracil. Exp Hematol. 1982 Jan;10(1):26–35. [PubMed] [Google Scholar]
  14. Humphries M. J., Komoriya A., Akiyama S. K., Olden K., Yamada K. M. Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem. 1987 May 15;262(14):6886–6892. [PubMed] [Google Scholar]
  15. Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969 Dec;74(3):223–234. doi: 10.1002/jcp.1040740303. [DOI] [PubMed] [Google Scholar]
  16. Jordan C. T., McKearn J. P., Lemischka I. R. Cellular and developmental properties of fetal hematopoietic stem cells. Cell. 1990 Jun 15;61(6):953–963. doi: 10.1016/0092-8674(90)90061-i. [DOI] [PubMed] [Google Scholar]
  17. Katayama M., Hino F., Odate Y., Goto S., Kimizuka F., Kato I., Titani K., Sekiguchi K. Isolation and characterization of two monoclonal antibodies that recognize remote epitopes on the cell-binding domain of human fibronectin. Exp Cell Res. 1989 Nov;185(1):229–236. doi: 10.1016/0014-4827(89)90051-7. [DOI] [PubMed] [Google Scholar]
  18. Kerst J. M., Sanders J. B., Slaper-Cortenbach I. C., Doorakkers M. C., Hooibrink B., van Oers R. H., von dem Borne A. E., van der Schoot C. E. Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way. Blood. 1993 Jan 15;81(2):344–351. [PubMed] [Google Scholar]
  19. Kimizuka F., Taguchi Y., Ohdate Y., Kawase Y., Shimojo T., Hashino K., Kato I., Sekiguchi K., Titani K. Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. J Biochem. 1991 Aug;110(2):284–291. doi: 10.1093/oxfordjournals.jbchem.a123572. [DOI] [PubMed] [Google Scholar]
  20. Kinashi T., Springer T. A. Steel factor and c-kit regulate cell-matrix adhesion. Blood. 1994 Feb 15;83(4):1033–1038. [PubMed] [Google Scholar]
  21. Leahy D. J., Aukhil I., Erickson H. P. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 1996 Jan 12;84(1):155–164. doi: 10.1016/s0092-8674(00)81002-8. [DOI] [PubMed] [Google Scholar]
  22. Liesveld J. L., Winslow J. M., Frediani K. E., Ryan D. H., Abboud C. N. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood. 1993 Jan 1;81(1):112–121. [PubMed] [Google Scholar]
  23. Martin P., Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science. 1982 Jun 11;216(4551):1233–1235. doi: 10.1126/science.6177045. [DOI] [PubMed] [Google Scholar]
  24. Meredith J. E., Jr, Fazeli B., Schwartz M. A. The extracellular matrix as a cell survival factor. Mol Biol Cell. 1993 Sep;4(9):953–961. doi: 10.1091/mbc.4.9.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mohri H., Katoh K., Iwamatsu A., Okubo T. The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells. Exp Cell Res. 1996 Feb 1;222(2):326–332. doi: 10.1006/excr.1996.0042. [DOI] [PubMed] [Google Scholar]
  26. Mojcik C. F., Salomon D. R., Chang A. C., Shevach E. M. Differential expression of integrins on human thymocyte subpopulations. Blood. 1995 Dec 1;86(11):4206–4217. [PubMed] [Google Scholar]
  27. Molla A., Berthier R., Chapel A., Schweitzer A., Andrieux A. Beta 1 integrins mediate adherent phenotype of human erythroblastic cell lines after phorbol 12-myristate 13-acetate induction. Biochem J. 1995 Jul 15;309(Pt 2):491–497. doi: 10.1042/bj3090491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Moritz T., Dutt P., Xiao X., Carstanjen D., Vik T., Hanenberg H., Williams D. A. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood. 1996 Aug 1;88(3):855–862. [PubMed] [Google Scholar]
  29. Moritz T., Patel V. P., Williams D. A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest. 1994 Apr;93(4):1451–1457. doi: 10.1172/JCI117122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Morla A., Zhang Z., Ruoslahti E. Superfibronectin is a functionally distinct form of fibronectin. Nature. 1994 Jan 13;367(6459):193–196. doi: 10.1038/367193a0. [DOI] [PubMed] [Google Scholar]
  31. Mould A. P., Komoriya A., Yamada K. M., Humphries M. J. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J Biol Chem. 1991 Feb 25;266(6):3579–3585. [PubMed] [Google Scholar]
  32. Neben S., Marcus K., Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood. 1993 Apr 1;81(7):1960–1967. [PubMed] [Google Scholar]
  33. O'Brien V., Frisch S. M., Juliano R. L. Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp Cell Res. 1996 Apr 10;224(1):208–213. doi: 10.1006/excr.1996.0130. [DOI] [PubMed] [Google Scholar]
  34. Papayannopoulou T., Craddock C. Homing and trafficking of hemopoietic progenitor cells. Acta Haematol. 1997;97(1-2):97–104. doi: 10.1159/000203665. [DOI] [PubMed] [Google Scholar]
  35. Papayannopoulou T., Craddock C., Nakamoto B., Priestley G. V., Wolf N. S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9647–9651. doi: 10.1073/pnas.92.21.9647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Papayannopoulou T., Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9374–9378. doi: 10.1073/pnas.90.20.9374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Papayannopoulou T., Priestley G. V., Nakamoto B. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood. 1998 Apr 1;91(7):2231–2239. [PubMed] [Google Scholar]
  38. Patel V. P., Lodish H. F. Loss of adhesion of murine erythroleukemia cells to fibronectin during erythroid differentiation. Science. 1984 Jun 1;224(4652):996–998. doi: 10.1126/science.6585955. [DOI] [PubMed] [Google Scholar]
  39. Pierschbacher M. D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 1984 May 3;309(5963):30–33. doi: 10.1038/309030a0. [DOI] [PubMed] [Google Scholar]
  40. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem. 1988;57:375–413. doi: 10.1146/annurev.bi.57.070188.002111. [DOI] [PubMed] [Google Scholar]
  41. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715. doi: 10.1146/annurev.cellbio.12.1.697. [DOI] [PubMed] [Google Scholar]
  42. Schwartz M. A., Lechene C., Ingber D. E. Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7849–7853. doi: 10.1073/pnas.88.17.7849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Shultz L. D., Schweitzer P. A., Christianson S. W., Gott B., Schweitzer I. B., Tennent B., McKenna S., Mobraaten L., Rajan T. V., Greiner D. L. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995 Jan 1;154(1):180–191. [PubMed] [Google Scholar]
  44. Sugahara H., Kanakura Y., Furitsu T., Ishihara K., Oritani K., Ikeda H., Kitayama H., Ishikawa J., Hashimoto K., Kanayama Y. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp Med. 1994 Jun 1;179(6):1757–1766. doi: 10.1084/jem.179.6.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Takahira H., Gotoh A., Ritchie A., Broxmeyer H. E. Steel factor enhances integrin-mediated tyrosine phosphorylation of focal adhesion kinase (pp125FAK) and paxillin. Blood. 1997 Mar 1;89(5):1574–1584. [PubMed] [Google Scholar]
  46. Teixidó J., Hemler M. E., Greenberger J. S., Anklesaria P. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest. 1992 Aug;90(2):358–367. doi: 10.1172/JCI115870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Terui Y., Furukawa Y., Sakai T., Kikuchi J., Sugahara H., Kanakura Y., Kitagawa S., Miura Y. Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes. J Immunol. 1996 Mar 1;156(5):1981–1988. [PubMed] [Google Scholar]
  48. Ugarova T. P., Ljubimov A. V., Deng L., Plow E. F. Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin. Biochemistry. 1996 Aug 20;35(33):10913–10921. doi: 10.1021/bi960717s. [DOI] [PubMed] [Google Scholar]
  49. Verfaillie C. M., McCarthy J. B., McGlave P. B. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med. 1991 Sep 1;174(3):693–703. doi: 10.1084/jem.174.3.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vuillet-Gaugler M. H., Breton-Gorius J., Vainchenker W., Guichard J., Leroy C., Tchernia G., Coulombel L. Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood. 1990 Feb 15;75(4):865–873. [PubMed] [Google Scholar]
  51. Whitney J. B., 3rd Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine. Biochem Genet. 1978 Aug;16(7-8):667–672. doi: 10.1007/BF00484723. [DOI] [PubMed] [Google Scholar]
  52. Williams D. A., Rios M., Stephens C., Patel V. P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature. 1991 Aug 1;352(6334):438–441. doi: 10.1038/352438a0. [DOI] [PubMed] [Google Scholar]
  53. Zhang Z., Vuori K., Reed J. C., Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6161–6165. doi: 10.1073/pnas.92.13.6161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. van der Sluijs J. P., Baert M. R., Ploemacher R. E. Differential adherence of murine hematopoietic stem cell subsets to fibronectin. Exp Hematol. 1994 Dec;22(13):1236–1243. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES